- Iqvia Holdings Inc IQV has collaborated with NRx Pharmaceuticals Inc NRXP to provide pharmacovigilance services and medical information in preparation for potential regulatory actions.
- IQVIA will work closely with NRx to support key activities required for emergency use authorization activation for Zyesami in COVID-19, including the pharmacovigilance and medical information programs.
- Related: NRx Pharma Stock Is Moving Higher On COVID-19 Candidate Data.
- Price Action: NRXP stock is up 6.90% at $11.73 during the premarket session on the last check Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in